ABOUT US
ABOUT US
About Us
When Alpha Analytical, the 7th largest environmental laboratory in the United States purchased Boston Analytical in 2009, they purchased a small laboratory started by a couple of college roommates over 30 years ago. Originally located in North Reading, Massachusetts that laboratory eventually become the current Boston Analytical located in Salem, New Hampshire. When Alpha Analytical purchased, it brought its wealth of laboratory operations experience to the team at Boston Analytical. Working with the Alpha team, Boston Analytical moved into a new 30,000 square foot facility in January 2017.
Boston Analytical is an agile company with a modern facility, expert staff, strong resources and the latest in technology. Our clients are impressed by the level of professionalism, technical knowhow, and expertise they experience with each interaction. They see how our Directors are involved in daily lab operations, are highly knowledgeable in their fields, and how they work collaboratively to solve project challenges both internally and for all our clients.
Our single point-of-contact project managers also help set us apart from others in the field. Each client is assigned to one of these highly qualified professionals who acts as their internal advocate from before a project starts to the final report and beyond. Our project managers all have experience in the pharmaceutical industry whether it was at Boston Analytical or another company.
Boston Analytical prides itself on utilizing the latest in technology with investments in LabWare LIMS™ (Laboratory Information Management System), LabWare ELN™ (Electronic Laboratory Notebook), Empower Data Chromatography Software, Qualtrax, Environmental Monitoring Programs, and BASIS (Boston Analytical Secure Information System) – our own client portal that allows clients to check the progress of their projects.
We look forward to sharing our whole story with you, please contact us today!
Current News
Boston Analytical has first FDA inspection in three years – resulting in zero observations
SALEM, New Hampshire - Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical, biopharmaceutical, and medical device industries is pleased to announce that their most recent FDA inspection resulted in no 483 observations....
read moreDirector’s Corner: Greg Slack, PhD
Greg is the Senior Director of a new area at Boston Analytical, Scientific Research and Services. In this role, he draws on his 20 years experience in scientific management and 10 years as a bench scientist to simplify and streamline internal business processes,...
read moreEssential Experts: Shaoyuan(Jim) Zhang, Ph.D.
Dr. Zhang has been with Boston Analytical since 2017 and works with the Extractables and Leachables (E&L) department as a senior scientist. He mainly focuses on Identification and quantification of non-volatile organic E&L compounds using LC-MS-TOF. Dr. Zhang also has...
read moreE&L Case Study for Cream-Gel Topical Drug Product
Abstract: Topical creams and gels are used to treat dermal conditions, and also incorporate the active ingredient of the drug transdermally into the circulatory system through the skin. Topical products have many applications, however they present unique leachables...
read moreDirector’s Corner: Yvonne Nyavor, PhD
Yvonne has been with Boston Analytical since 2021 and works with the Microbiology Department as the Principal Scientist for Microbiome. In Addition, Yvonne works with Business Development and Client Services, and collaborates with Analytical Development, Raw...
read more